Coronavirus treatment: how to enroll in hydroxychloroquine study

An old, generic malaria drug has rapidly become a leading potential coronavirus treatment, as President Donald Trump has repeatedly touted its potential against the virus and the US government has built up a massive stockpile of the medication.

Nationwide study of health practitioners, first responders examines use of anti-malarial drug to counter COVID-19

Sarah Lofgren’s voice had a tinge of excitement when she explained why the bright green dots on one scientific slide disappeared on the next. The co-investigator at the University of Minnesota Division of Infectious Disease and International Medicine showed how SARS, or severe acute respiratory syndrome, represented by those green dots, responded to all the drugs that were thrown at it to determine what could hinder the virus.

Pharmaceutical Companies Lend Support to Hydroxychloroquine Clinical Trials for COVID-19

Pharmaceutical companies Novartis and Rising Pharmaceuticals are taking action to support the latest clinical trials exploring hydroxychloroquine as a treatment for the coronavirus disease 2019 (COVID-19).

Rising Pharma in partnership with Laurus Labs to collaboration University of Minnesota

For a clinical trial exploring hydroxychloroquine as preventive treatment for COVID-19